EICHORCondition: Metastatic Colorectal Cancer (CRC) · Sponsor: Summit Therapeutics
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer(HARMONi-GI3)
This description comes directly from the study's public registry record.
Ning Chang, MD · 1-833-256-0522 · medicalaffairs@summitplc.com
Always discuss trial participation with your own doctor first.
| Clinical Study Site | Mobile, Alabama, United States | Recruiting |
| Clinical Study Site | Tuscaloosa, Alabama, United States | Recruiting |
| Clinical Study Site | Goodyear, Arizona, United States | Recruiting |
| Clinical Study Site | Beverly Hills, California, United States | Recruiting |
| Clinical Study Site | Beverly Hills, California, United States | Recruiting |
| Clinical Study Site | Cerritos, California, United States | Recruiting |
| Clinical Study Site | Corona, California, United States | Recruiting |
| Clinical Study Site | Duarte, California, United States | Recruiting |
| Clinical Study Site | Fountain Valley, California, United States | Recruiting |
| Clinical Study Site | Huntington Beach, California, United States | Recruiting |
| Clinical Study Site | Irvine, California, United States | Recruiting |
| Clinical Study Site | Irvine, California, United States | Recruiting |
+ 154 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07228832